Survival and prognostic factors in systolic heart failure with recent symptom onset;Sobrevida e fatores prognósticos na insuficiência cardíaca sistólica com início recente dos sintomas

Arquivos Brasileiros de Cardiologia

Volumn 84, Issue 4, 2005, Pages 309-313

  Rassi, Salvador ^a,b   Pereira Barretto, Antônio Carlos ^a   Porto, Celmo Celeno ^a   Pereira, Crésio Romeu ^a   Calaça, Barbara Wosjunk ^a   Rassi, Daniela C ^a  

^a Setor Universitário ^*

^b Setor Universitario   (Brazil)

Author keywords

Analysis of survival; Epidemiology; Heart failure; Prognosis

Indexed keywords

CREATININE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CARDIOVASCULAR SYMPTOM; CHAGAS DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART RATE; HEART SOUND; HEART VENTRICLE FUNCTION; HUMAN; HYPOTENSION; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HEART FAILURE; TACHYCARDIA;

EID: 18844412121     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0066-782x2005000400007     Document Type: Article

References (25)

1. Madsen BK, Hansen JF, Stokholm KH et al. Chronic congestive heart failure. Description and survival of 190 consecutive patients with a diagnosis of chronic congestive heart failure based on clinical signs and symptoms. Eur Heart J 1994; 15: 303-10.
2. Bettencourt P, Ferreira A, Dias P et al. Predictors of prognosis in patients with stable mild to moderate heart failure. J Card Fail 2000; 6: 306-13.
3. Mosterd A, Cost B, Hoes AW et al. The prognosis of heart failure in the general population. The Rotterdam Study. Eur Heart J 2001; 22: 1318-27.
4. II Diretrizes da Sociedade Brasileira de Cardiologia para Diagnóstico e Tratamento da Insuficiência Cardíaca. Arq Bras Cardiol 1998; 72 (Supl I).
5. Colquhoun MC, Waine C, Monaghan MJ et al. Investigation in general practice of patients with suspected heart failure. How should the essential echocardiographic service be delivered? Br Heart J 1995; 74: 335-6.
6. Mosterd A, de Bruijne MC, Hoes AW et al. Usefulness of echocardiography in detecting left ventricular dysfunction in population based studies (The Rotterdam Study). Am J Cardiol 1997; 79: 103-11
7. The Task Force of the Working Group on Heart Failure of the European Society of Cardiology. The treatment of heart failure. Eur Heart J 1997; 18: 736-53.
8. Kaplan EL, Meier P. Nomparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81
9. Cox DR. Regression models and life-tables. J R Stat Soc 1972; 39: 86-94.
10. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): a randomised trial. Lancet 1999; 353: 9-13.
11. MERIT-HF Study Groups. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999; 353: 2001-7.
12. The SOLVD Investigators. Effects of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302.
13. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995; 273: 1450-6.
14. Senni M, Tribouillory CM, Rodeheffer RJ et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998; 98: 2282-9.
15. Cowie MR, Wood DA, Coats AJS et al. Survival of patients with a new diagnosis of heart failure: a population-based study Heart 2000; 82: 505-10.
16. Cowie MR, Fox KF, Wood DA et al. Hospitalization of patients with heart failure. A population-based study. Eur Heart J 2002; 23: 877-85.
17. Ho KKL, Anderson KM, Kannel WB et al. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993; 88: 107-15.
18. Adams KF, Dunlap SH, Sueta CA et al. Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol 1996; 28: 1781-8.
19. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429-35.
20. Likoff MJ, Chandler SL, Kay HR. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol 1987; 59: 634-8.
21. Aaronson KD, Schwartz JS, Chen T et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997; 95: 2660-7.
22. Alla F, Briançon S, Juillière Y et al. Differential clinical prognostic classifications in dilated and ischemic advanced heart failure: the EPICAL study. Am Heart J 2000; 139: 895-904.
23. McMurray JJ, Stewart S. Heart Failure. Epidemiology, aetiology and prognosis of heart failure. Heart 2000; 83: 596-602.
24. Grzybowski J, Bilinska ZT, Ruzyllo W et al. Determinants of prognosis in nonischemic dilated cardiomyopathy. J Card Fail 1996; 2: 77-85.
25. Lee WH, Packer M. Prognostic importance of serum sodium concentration and its modification by converting enzyme inhibition in patients with severe chronic heart failure. Circulation 1986; 73: 257-67.